相关实验视频
Updated: May 17, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
儿科甲状腺癌:遗传革命及其对治疗及其结果的影响
Joel A Vanderniet1,2,3, Noemi A Fuentes-Bolanos4,5, Yoon Hi Cho1,2
1Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2050, Australia.
分子测试促进了对儿科甲状腺癌的理解,识别了基因变异,并使有针对性的治疗成为可能. 这种方法有望改善风险评估,减少儿童和青少年不必要的手术.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 儿科 儿科 儿科
背景情况:
- 儿童甲状腺癌的理解已经增长,揭示了不同的分子变化,如基因融合,通常与侵入性疾病有关.
- 与成年人不同,儿科病例显示出较少的点突变和癌症倾向基因的显著作用,需要仔细评估家族病史.
- 分子检测,在成年人中验证甲状腺结节,在儿科护理中正在出现,尽管数据仍然有限.
研究的目的:
- 审查当前关于小儿甲状腺癌分子变化的知识.
- 评估支持儿童临床实践中分子测试的证据.
- 概述该领域未来的研究方向.
主要方法:
- 在小儿甲状腺癌中分子变化的文献综述.
- 对分子测试临床实用性的证据分析.
- 讨论新兴的研究和未来的方向.
主要成果:
- 分子诊断有助于针对晚期或耐放射性的儿科甲状腺癌的向治疗.
- 分子测试可以增强儿科甲状腺结节的风险分层,可能减少诊断性叶切除术.
- 新出现的数据表明,分子测试可以减少手术干预和并发症,而不会影响结果.
结论:
- 分子分析对于儿童甲状腺癌个性化治疗策略至关重要.
- 分子测试具有显著的潜力,可以完善风险评估,并最大限度地减少儿童甲状腺结节的过度治疗.
- 需要进一步的研究,才能将分子测试完全整合到儿科甲状腺癌的标准管理中.
更多相关视频
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
相关概念视频
Gene Therapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
What is Genetic Engineering?
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...